CSF1R and prostate cancer: Taken together, through single-cell assessment, our data enabled us to identify analogous Spp1hi-TAMs with elevated immunosuppressive gene signatures across multiple mouse models of prostate cancer, and we subsequently demonstrated their resistance to CSF1R inhibition.